New non-prescription nerve pain management treatment available in the U.S.
Neuragen® relieves pain caused by diabetic nerve damage
September 9, New York – Origin BioMed recently launched its lead
product Neuragen® in the United States. Neuragen® is the first
non-prescription topical homeopathic treatment for rapid relief of
diabetic and post-shingles nerve pain.
Neuragen® is effective in relieving pain in a variety of nerve related
conditions. It offers distinct advantages with few or no side effects
and a high level of efficacy. Neuragen® works in 5 to 20 minutes and
provides up to eight hours of relief.
“Until recently, over-the-counter treatment options for nerve pain have
been limited,” said Robert Cervelli, President and CEO, Origin BioMed.
“Now that Neuragen® is available in the United States, nerve pain
sufferers will be able to significantly improve their quality of life,”
he added.
In the United States, approximately 23 million children and adults or
7% to 8% of the population have diabetes. While an estimated 17.9
million have been diagnosed with diabetes, 5.7 million people are
unaware that they have the disease. Diabetic nerve pain occurs when
high blood sugar levels damage nerves producing symptoms in about 60%
to 70% of diabetics. It affects hands and feet with symptoms of
numbness, tingling and pain, which may include burning and cold
sensations.
"I have seen the benefits of Neuragen® in providing rapid and sustained
pain relief among patients,” said Susan Sloane, Registered Pharmacist,
CDE,CPT. “This is an exciting breakthrough in the treatment of nerve
pain because it is so easy to use and results may be seen in as little
as five minutes. In scientific studies Neuragen® performed
exceptionally well, confirming pain relief in greater than 70 percent
of patients in some cases. Neuragen® is truly an impressive product
with huge benefits for so many patients with diabetes who suffer from
painful diabetic nerve damage."
Neuragen is available in leading pharmacies nationwide.
-30-
About Origin BioMed Inc.
Origin BioMed, Inc. is a privately-held Canadian consumer health
products company with business operations throughout the U.S. and
Canada. Headquartered in Halifax, Nova Scotia, Origin BioMed Inc.
manufactures health products with the highest quality active
ingredients, at therapeutic levels, with evidence of scientific or
clinical efficacy since 2001. Its leading drug product, Neuragen®,
helps relieve pain caused by diabetic nerve damage. For more
information, please visit: www.originbiomed.com or www.neuragen.com.
Origin BioMed is continuing its North American market expansion with
additional financing. In July 2008, the company received $5.1 million
in follow-on financing led by Calgary-based Avrio Ventures Management
Corporation and Nova Scotia Business Inc. Venture Capital in support of
Origin’s continued growth. This new financing is helping drive the
company’s market expansion, placing Neuragen® on American drug store
shelves, and supporting the growth of its U.S.-based operations.
Contact:
Robert Silverstein
Senior Sales and Marketing Director
902-444-8696
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
|
|
Last Updated ( Sunday, 21 September 2008 )
|
